/ The Lancet Global Health

Fluvoxamine for the treatment of COVID-19.

Marzolini C, Marra F, Boyle A, Khoo S, Back DJ.

Lancet Glob Health. 2022 Mar;10(3):e331.
doi: 10.1016/S2214-109X(21)00592-1. PMID: 35180411; PMCID: PMC8846616.